In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, according to AlpVision.

Published: 07-May-2013

ASI has teamed up with Chromatan in order to deliver single-use and column-free capture purification services which could save clients 65% in chromatography costs in clinical manufacturing.

Published: 30-Apr-2013

Excipient firms that skip lot testing or use alternative analysis methods should justify their decisions according to a new COA guide issued by IPEC Americas. 

Published: 21-Feb-2013

BASF is moving en masse into omega-3 - especially if its bid for Norwegian player Pronova is approved - but it is technology gained from its May acquisition of a high-dose omega-3 start-up on a remote Scottish island, that is exciting the German giant.

Published: 13-Dec-2012

The positive impact drug industry demand for quality is having on the fine chemicals sector was evident at industry trade show CPhI last month according to expert Jan Ramakers. 

Published: 31-Oct-2012

Capsugel has expanded its Licaps liquid fill capsule line with a new facility in the US.

Published: 17-Oct-2012

Sartorius Stedim says its new range of sterilising-grade filters can allow steam cleaning in dry conditions and minimises protein binding.

Published: 26-Jun-2012

Submitting a REMS (Risk Evaluation and Mitigation Strategies) proposal for risky drug developments could earn companies brownie points, according to Quintiles’ Ed Tabor.

Published: 13-Jun-2012

A bigger initial pay-out for REMS means long-term profitability for drugsmakers, says Quintiles Ed Tabor.

Published: 06-Jun-2012

Developments in single-use technology signals the end for clean-in-place biomanufacturing methods, according to ThermoFisher’s Bill Whitford.

Published: 21-May-2012

Reduce changeover time on oral solid dose machinery by cleaning equipment offline, Fette Compacting urged drugsmakers at this year’s Interphex.

Published: 10-May-2012

Advancements in single-use equipment are crucial to the development of the biotechnology industry, according to experts at this year’s Interphex.

Published: 07-May-2012

Planning supply chains early is an important part of maintaining margins but is often overlooked by Pharmas too focused on developing the next product in an era of patent expiry says industry consultant.

Published: 26-Mar-2012

Acuros is seeking development partnerships with Big Pharma over its recently launched water-powered drug delivery pump.

Published: 13-Mar-2012

Reduced-pain injection systems are the key to gaining regulatory approval for new products, according to BD.

Published: 28-Feb-2012

Unilife is expanding its large dose delivery platform in a bid to meet a “growing industry need” for at-home drug administration in bigger scale.

Published: 23-Feb-2012

Aptar Pharma says its new eDevices can help companies gain quicker regulatory approval for their nasal drug products without having to re-do clinical trials.

Published: 21-Feb-2012

Excipient makers could save up to 200 man hours with a new industry-driven, third-party audit certification scheme set to launch next week.

Published: 17-Jan-2012

Taste masking plays a vital role in treatment compliance according to Cargill, which has launched a new flavour technology that it claims can make drugs more pleasant to take and help manufacturers save money.

Published: 30-Nov-2011

High potency APIs are becoming a key focus of the pharmaceutical business, with drug makers from all areas racing to establish a foothold in the market.

Published: 29-Nov-2011

Endeavour Specialty Chemicals has launched a novel range of pyridinyl thioureas designed to cater for growing pharmaceutical industry interest in the development of prion disease treatments.

Published: 16-Nov-2011

BASF says solubility and bioavailability will be key focus for its pharmaceutical excipient product development efforts in the next few years.

Published: 31-Oct-2011

April saw the publication of the second draft of Excipact, a set of certification standards for third-party auditors of excipient manufacturers.

Published: 08-Jun-2011

Pharma needs to learn from other sectors and abandon the multistage development paradigm in favour of a two-stage design and manufacturing model to cut attrition rates.

Published: 25-May-2011